- Home
- VRAX vs IMTE Comparison
VRAX vs IMTE Comparison
Compare VRAX & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- IMTE
- Stock Information
- Founded
- VRAX 2013
- IMTE 2008
- Country
- VRAX United Kingdom
- IMTE Malaysia
- Employees
- VRAX N/A
- IMTE N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IMTE Consumer Electronics/Appliances
- Sector
- VRAX Health Care
- IMTE Consumer Staples
- Exchange
- VRAX Nasdaq
- IMTE Nasdaq
- Market Cap
- VRAX 4.7M
- IMTE 4.1M
- IPO Year
- VRAX 2022
- IMTE N/A
- Fundamental
- Price
- VRAX $0.81
- IMTE $0.99
- Analyst Decision
- VRAX Strong Buy
- IMTE
- Analyst Count
- VRAX 1
- IMTE 0
- Target Price
- VRAX $3.00
- IMTE N/A
- AVG Volume (30 Days)
- VRAX 37.2K
- IMTE 10.6K
- Earning Date
- VRAX 02-05-2025
- IMTE 07-07-2025
- Dividend Yield
- VRAX N/A
- IMTE N/A
- EPS Growth
- VRAX N/A
- IMTE N/A
- EPS
- VRAX N/A
- IMTE N/A
- Revenue
- VRAX $84,872.00
- IMTE $123,337.00
- Revenue This Year
- VRAX $5,169.18
- IMTE N/A
- Revenue Next Year
- VRAX $66.97
- IMTE N/A
- P/E Ratio
- VRAX N/A
- IMTE N/A
- Revenue Growth
- VRAX 7.03
- IMTE 4.75
- 52 Week Low
- VRAX $0.75
- IMTE $0.51
- 52 Week High
- VRAX $9.00
- IMTE $3.17
- Technical
- Relative Strength Index (RSI)
- VRAX 31.75
- IMTE 34.23
- Support Level
- VRAX $0.75
- IMTE $0.87
- Resistance Level
- VRAX $0.85
- IMTE $1.02
- Average True Range (ATR)
- VRAX 0.07
- IMTE 0.05
- MACD
- VRAX -0.01
- IMTE -0.01
- Stochastic Oscillator
- VRAX 6.57
- IMTE 41.93
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.